Exhibiting at VIV Asia 2025

Amcovet Co., Ltd.: Advancing Veterinary Pharmaceuticals and Animal Health

Amcovet Co., Ltd., headquartered in Bangkok, Thailand, is a leading manufacturer of veterinary pharmaceuticals and animal health solutions. With a commitment to scientific innovation, high-quality formulations, and sustainable animal healthcare, Amcovet has established itself as a trusted partner for veterinarians, livestock producers, and animal health professionals worldwide.

Core Business and Specialization

Amcovet specializes in developing and manufacturing veterinary medicines, focusing on disease prevention, therapeutic treatments, and performance enhancement for livestock and companion animals. The company’s key areas of expertise include:

• Antibiotics & Antimicrobials – Cutting-edge formulations to treat bacterial infections
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) – Safe and effective pain relief solutions
• Veterinary Vaccines – Preventive immunization against infectious diseases
• Antibiotic Replacements & Immune Modulators – Probiotic and enzyme-based therapies
• Probiotics & Prebiotics – Gut health solutions for improved animal digestion and immunity

With a strong research-driven approach, Amcovet ensures high bioavailability, safety, and regulatory compliance in all its products.

Product and Service Offerings

1. Antibiotics & Antimicrobials

Amcovet develops broad-spectrum antibiotics for livestock, poultry, and companion animals:

• Marbocyl 10% – A potent fluoroquinolone antibiotic for bacterial infections
• Other antibiotic formulations targeting respiratory, digestive, and skin infections

2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Designed for pain management and inflammation control, key products include:

• Tolfedine CS – A highly effective NSAID for livestock and pets

3. Veterinary Vaccines

Amcovet’s vaccines protect against viral and bacterial diseases:

• Synparv – A specialized vaccine for canine parvovirus prevention

4. Antibiotic Replacements & Immune Modulators

Amcovet is a pioneer in non-antibiotic alternatives, offering:

• Dysguard-S – A specialized supplement to promote gut health and immunity
• LF-Lysozyme 10% – An enzyme-based solution for pathogen control

5. Probiotics & Prebiotics

Amcovet focuses on gut microbiome health with probiotic solutions such as:

• Sporezyme-Forte – A multi-strain probiotic for enhanced digestion and immunity

Market Position and Global Reach

With a strong presence across Asia, the Middle East, and Africa, Amcovet is a preferred supplier for veterinary professionals and livestock industries.

• More than 500 veterinary products registered globally
• Annual production capacity exceeding 20,000 metric tons
• Partnerships with over 100 animal health distributors worldwide

Shipment Data and Export Markets

Amcovet exports high-quality veterinary pharmaceuticals to major markets, including:

• Southeast Asia (Vietnam, Indonesia, Philippines) – Demand for livestock antibiotics and vaccines
• Middle East & Africa – Growing need for poultry disease management solutions
• Latin America – Expanding market for antibiotic alternatives in animal production

Certifications and Compliance

Amcovet maintains rigorous quality control standards, ensuring safety and efficacy through:

• GMP (Good Manufacturing Practice) Certification for veterinary pharmaceuticals
• ISO 9001:2015 Certification for quality assurance
• WHO & FDA Compliance – Meeting global veterinary medicine safety standards

The company is dedicated to responsible antibiotic use, aligning with global efforts to combat antimicrobial resistance (AMR).

Customer Testimonials and Industry Recognition

Amcovet’s products are highly regarded by veterinarians, livestock producers, and industry experts:

• “Amcovet’s Marbocyl 10% has significantly improved recovery rates in our poultry farms, reducing mortality by 30%.” – Poultry Producer, Thailand
• “Their probiotic solutions have enhanced gut health in our dairy herds, leading to a 15% increase in milk yield.” – Dairy Farm Manager, Vietnam

Recognized for innovation in veterinary medicine, Amcovet has received:

• Best Veterinary Pharmaceuticals Manufacturer – Thailand (2023)
• Top 10 Animal Health Companies in Asia (2022)

Major Achievements and Future Growth

• Investment in AI-driven veterinary diagnostics and precision medicine
• Expansion into European and North American markets
• Research and development of next-generation antibiotic alternatives

With a commitment to innovation, sustainability, and animal welfare, Amcovet continues to lead the global veterinary pharmaceutical industry.